We set the hyperparameters for both DNN and HONN by optimizing their performance on the validation set (20% of the training data) for each target allele. The found sets of parameters were used for training on the full train dataset(IEDB) and making predictions for the corresponding test data of each target allele. The selected set of hyperparameters is shown in Table S1 . Table S1 : DNN and HONN hyperparameters used for training and pre-training
Supplementary Information 1 Model hyperparameters
We set the hyperparameters for both DNN and HONN by optimizing their performance on the validation set (20% of the training data) for each target allele. The found sets of parameters were used for training on the full train dataset(IEDB) and making predictions for the corresponding test data of each target allele. The selected set of hyperparameters is shown in Table S1 . Tables S2, S4, S6 show the quality of ranking (nDCG) MHC-peptide interactions on test data using DNN trained with or without pre-training. Similarly, Tables S3, S5 , S7 show the quality of ranking MHC-peptide interactions using high-order neural network (HONN) trained with or without pre-training. Pre-training of the models consistently improves their performance. 3 Evaluation on benchmark IEDB data
To further evaluate performance of proposed methods, we used recent benchmark MHC-I binding datasets from (Kim et al., 2014) . We first trained a deep neural network (DNN), a proposed high-order semi-RBM (HONN), and a highorder kernel SVM (hkSVM) on BD2009 binding datasets (Kim et al., 2014 ) for each allele. We then tested on the independent blind dataset (BLIND) for each MHC-I allele. Table S8 shows training (BD2009) and independent test (BLIND) datasets used for evaluation.
To train HONN, we first select hyper-parameters (number of hidden units and learning rate) on the validation set (20% of the training BD2009 allele data). Selected hyper-parameters are then used to train on the full training dataset. Trained models are then tested on the independent BLIND test sets for each allele. Table S9 shows AUC and ROC-n scores for the high-order kernel SVM (hkSVM), high-order semi-RBM (HONN), and NetMHC method (Nielsen et al., 2003; Buus et al., 2003; Lundegaard et al., 2011) . As can be seen from the results in the table, while the area under ROC curve (AUC) scores are very similar for both our method and the NetMHC method (AUC scores of 92.875 and 92.375), for the very highest ranked peptides (low false positive (FP) rates), both hkSVM and HONN+hkSVM perform better on average compared to NetMHC as measured by ROC-n scores (e.g., ROC-1 scores of hkSVM or HONN are higher in about 67% (31/46) of the tested alleles and tied in 22% (10/46) of the tested alleles).
Peptide binding prediction scores on the test (BLIND) datasets for each allele are provided in the supplementary data (hksvm_honn_blind_predict.tar.gz). -BD2009 1626  181  1445  B1801-BLIND  503  28  475  A0206-BD2009 3122  1211  1911  A0206-BLIND  482  251  231  A0101-BD2009 3102  383  2719  A0101-BLIND  479  77  402  A3001-BD2009 1933  567  1366  A3001-BLIND  470  151  319  A6901-BD2009 2073  220  1853  A6901-BLIND  470  26  444  B1509-BD2009  345  16  329  B1509-BLIND  466  29  437  A0203-BD2009 3822  1205  2617  A0203-BLIND  460  255  205  A6802-BD2009 3085  607  2478  A6802-BLIND  457  188  269  B2703-BD2009  433  0  433  B2703-BLIND  441  0  441  A2501-BD2009  519  66  453  A2501-BLIND  416  5  411  A2602-BD2009  202  67  135  A2602-BLIND  413  99  314  A8001-BD2009  774  111  663  A8001-BLIND  379  7  372  B4601-BD2009 1355  77  1278  B4601-BLIND  378  0  378  B3801-BD2009  136  3  133  B3801-BLIND  351  141  210  A2402-BD2009 1904  316  1588  A2402-BLIND  346  136  210  B3501-BD2009 1945  478  1467  B3501-BLIND  341  162  179  A2603-BD2009  205  25  180  A2603-BLIND  312  37  275  A6801-BD2009 1665  629  1036  A6801-BLIND  312  186  126  B5301-BD2009  576  190  386  B5301-BLIND  296  120  176  A3301-BD2009 1579  223  1356  A3301-BLIND  288  161  127  B5801-BD2009 2371  367  2004  B5801-BLIND  275  158  117  A3002-BD2009  867  230  637  A3002-BLIND  267  103  164  A3201-BD2009  569  275  294  A3201-BLIND  256  120  136  B4402-BD2009 1262  101  1161  B4402-BLIND  250  129  121  B2705-BD2009 2294  335  1959  B2705-BLIND  249  26  223  B4001-BD2009 2288  274  2014  B4001-BLIND  243  100  143  A2301-BD2009 1429  269  1160  A2301-BLIND  242  86  156  B0803-BD2009  217  9  208  B0803-BLIND  234  9  225  B4403-BD2009  474  96  378  B4403-BLIND  205  103  102  B1503-BD2009  404  331  73  B1503-BLIND  165  33  132  A0202-BD2009 2212  1003  1209  A0202-BLIND  126  44  82  A2902-BD2009 1736  427  1309  A2902-BLIND  118  27  91  B5401-BD2009  577  127  450  B5401-BLIND  79  5  74  B4002-BD2009  450  154  296  B4002-BLIND  74  18  56  B4501-BD2009  459  101  358  B4501-BLIND  65  5  60 Table S9 : Comparison of AUC scores on independent (BLIND) dataset for human MHC-I alleles. Proposed methods display state-of-the-art prediction performance when tested across 46 human MHC-I alleles. Observed improvements in ROC-n scores (low FP rates) are significant (paired signed rank test P-values=7e-3 and 1.38e-2 for hkSVM and HONN+hkSVM, respectively). 4 Naturally-processed peptide prediction
To train our models, we used the data from Machine Learning in Immunology competition (MLI-II) http://bio.dfci.harvard.edu/DFRMLI/HTML/natural. php. For each of the MHC-I alleles, a set of 8-to 11-mer peptides is given for training and testing. We directly train our models to recognize naturally processed and presented (NP) peptides, using "eluted" peptides as a positive set, and all other peptides (non-binders + non-eluted binders) as a negative set. We then test our models on the data composed of non-eluted binding peptides, non-binding peptides, and naturally processed ("eluted") peptides. We used the same training and test split as specified in the competition. In Table S11 , we compare our approach hkSVM with the popular NetMHC method, which was used as a benchmark in the competition, as well as the recently introduced MHC-NP (Gigure et al., 2013) method that yielded state-of-the-art accuracy for naturally processed (NP) peptide prediction. (Gigure et al., 2013) 
